Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    ICT-107
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo DC
2 Recruiting Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo

Indicates status has not been verified in more than two years